Analysts' Actions: AMGN BIIB DWA FCX ULTI

TheStreet.com

NEW YORK (TheStreet) -- CHANGE IN RATINGS

Amgen was upgraded at Goldman Sachs to buy from neutral. $130 price target. Company was also added to the Conviction Buy List, as the company has multiple potential catalysts, Goldman said.

Biogen Idec was downgraded at Goldman Sachs to neutral from buy. $215 price target. Valuation call, as the stock is up 44% since December, Goldman said.

CapitalSource was downgraded to hold at TheStreet Ratings.

Dreamworks was upgraded at Bank of America/Merrill Lynch to neutral. $22 price target. Company appears to be at a positive inflection point, BofA/Merrill said.

Freeport-McMoran was upgraded at Nomura to buy from neutral. $38 price target. Company prices appear oversold, and valuation multiples should expand, Nomura said.

Fiserv was downgraded at Oppenheimer to perform from outperform. Valuation call, based on an $89 price target, Oppenheimer said.


LSI was downgraded at Goldman Sachs to neutral from buy. $7 price target. Company is leveraged to weak enterprise spending and lower PC demand, Goldman Sachs said.

Nuance was downgraded at Morgan Stanley to equal-weight. Company is facing increased growth risks, Morgan Stanley said.

Oil States was downgraded at BMO Capital to underperform. Valuation call, based on an $82 price target, BMO Capital said.

Oneok was downgraded at Morgan Stanley to equal-weight. $53 price target. Stock is up 20% year to date, despite deteriorating fundamentals, Morgan Stanley said.

Opko Health was downgraded to hold at TheStreet Ratings.


Ultimate Software was upgraded at Canaccord Genuity to buy. $110 price target. Company is carrying a lot of momentum into the new year, Canaccord said.

STOCK COMMENTS/EPS CHANGES

Aetna estimates, price target were raised at BMO Capital. Shares are now seen reaching $64. Estimates were also increased, given improving core trends, BMO Capital said. Outperform rating.

Artisan Partners Asset Management price target and estimates were increased at Citigroup. Solid flows, underlying margin dynamics and favorable FCF, said Citigroup. Price target goes to $47.

Avon estimates, price target were boosted at BMO Capital. Shares are now seen reaching $27. Estimates were also increased, as the company is realizing higher margins, BMO Capital said. Outperform rating.


Cummins price target and estimates were reduced at UBS. Reflects the first-quarter miss, lower potential operating margins and a higher tax rate, said UBS. Price target goes to $126.

DSW price target and estimates were reduced at Canaccord Genuity. Estimates were cut to reflect weak comp trends that continued into April, said Canaccord Genuity. Price target goes to $65.

Ecolab estimates, price target were raised at Credit Suisse. Shares are now seen reaching $86. Estimates were also increased, as the company continues to execute well, Credit Suisse said. Outperform rating.

Express Scripts numbers were increased at BMO Capital. Estimates were increased through 2014. Company continues to execute on its plan, BMO Capital said. Market Perform rating and new $62 price target.

Fidelity National Information price target and estimates were increased at UBS. International sales growth is expected to be industry-leading, UBS said. Price target goes to $48.

Fiserv price target was increased at UBS to $91 as the company focuses on paying down debt, said UBS.

Fortinet price target and earnings were reduced at UBS. Estimates were reduced on what is considered kitchen-sink type guidance from the new CFO, said UBS. Price target goes to $25.

Starwood estimates, price target were increased at BMO Capital. Estimates were increased through 2014. Bal Harbour is driving growth, BMO Capital said. Market perform rating and new $70 price target.

Hertz price target and estimates were increased at Goldman Sachs. Earnings estimates were raised given favorable pricing trends, said Goldman Sachs. Price target goes to $28.50.

Invesco price target and estimates were increased at Citigroup. Earnings estimates were increased as stronger cost controls are expected to lead to margin expansion, said Citigroup. Price target goes to $39.

Jacobs Engineering numbers were boosted at Credit Suisse. Shares are now seen reaching $58. Estimates were also increased, as the company is realizing higher margins, Credit Suisse said. Outperform rating.

MeadWestvaco price target and earnings were reduced at UBS. Estimates were reduced on the disappointing first-quarter result, though the second half of the year should see improvements, said UBS. Price target goes to $34.

Nasdaq OMX Group price target and estimates were reduced at Citigroup. Earnings estimates were reduced as expenses increased and buybacks were suspended due to the eSpeed acquisition, said Citigroup. Price target goes to $30.

NiSource price target and estimates were increased at UBS. Earnings estimates were increased given rate case updates and an affirmed guidance, said UBS. Price target goes to $30.

Public Service Enterprise Group price target and estimates were increased at UBS. Earnings estimates were increased due to higher power prices and increased generation in the company's coal and gas fire units, said UBS. Price target goes to $38.

Pfizer estimates were reduced at UBS. Reflects the impact of FX, said UBS.

Regeneron Pharmaceuticals price target and estimates were increased at Goldman Sachs. Earnings estimates were raised on Eylea growth and the pipeline, said Goldman Sachs. Price target goes to $240.

Vertex Pharma price target and estimates were increased at UBS. Reflects faster penetration of CF, said UBS. Price target goes to $86.

Western Union estimates were increased at Citigroup due to increased buybacks, but also reflect transaction weakness, said Citigroup.

Western Union numbers were increased at Credit Suisse through 2014. Company is seeing higher transaction rates and buying back stock, Credit Suisse said. Neutral rating and new $17 price target.

U.S. Steel estimates, price target were cut at Credit Suisse. Shares are now seen reaching $24. Estimates were also reduced, given the company's new guidance, Credit Suisse said. Outperform rating.

>To submit a news tip, email: tips@thestreet.com.

Follow TheStreet on Twitter and become a fan on Facebook.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE.

View Comments